Increased levels of circulating CTRP9 in individuals with T2DM and CAD suggest a compensatory response to insulin resistance, inflammatory milieu, and endothelial dysfunction [50] (Figure 4). The gene discussed is C1QTNF9; the disease is type 2 diabetes mellitus.